speb/financial-data huggingface dataset:
EQX.TO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -839981000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -839981000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 928332000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 928332000.00
EQX.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 630306219.00
EQX.TO income_statement (annual, 2025-12-31) — Basic EPS: 0.35
EQX.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 239329000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 359704000.00
EQX.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -692346000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -267080000.00
EQX.TO cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -692346000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -267080000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 73691000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 73691000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 4874712000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 4874712000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 407355000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 407355000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 570038000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 570038000.00
EQX.TO cash_flow (annual, 2025-12-31) — Cash Dividends Paid: 0.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: 0.00
EQX.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -171893000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -131991000.00
EQX.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -458673000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -187569000.00
EQX.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 818345000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 390150000.00
EQX.TO cash_flow (annual, 2025-12-31) — Change In Account Payable: 29922000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 58304000.00
EQX.TO cash_flow (annual, 2025-12-31) — Change In Inventory: -157791000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Change In Inventory: -101004000.00
EQX.TO cash_flow (annual, 2025-12-31) — Change In Payable: 29922000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Change In Payable: 58304000.00
EQX.TO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 29922000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 58304000.00
EQX.TO cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 17791000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -1079000.00
EQX.TO cash_flow (annual, 2025-12-31) — Change In Receivables: 13320000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Change In Receivables: 40181000.00
EQX.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: -96758000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -3598000.00
EQX.TO cash_flow (annual, 2025-12-31) — Changes In Cash: 187779000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: 70590000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Common Stock: 4874712000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 4874712000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 5795307000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 5795307000.00
EQX.TO cash_flow (annual, 2025-12-31) — Common Stock Issuance: 0.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
EQX.TO balance_sheet (annual, 2025-12-31) — Construction In Progress: 39565000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 39565000.00
EQX.TO income_statement (annual, 2025-12-31) — Cost Of Revenue: 1175091000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: -73141000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 189628000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 189628000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Current Assets: 1970557000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 1970557000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Current Debt: 181330000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Current Debt: 181330000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 181330000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 181330000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 127597000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 127597000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 127597000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 127597000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Current Liabilities: 1261974000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 1261974000.00
EQX.TO cash_flow (annual, 2025-12-31) — Deferred Income Tax: 191119000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 125613000.00
EQX.TO cash_flow (annual, 2025-12-31) — Deferred Tax: 191119000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Deferred Tax: 125613000.00
EQX.TO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 517516000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 151848000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 46710000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 46710000.00
EQX.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 630306219.00
EQX.TO income_statement (annual, 2025-12-31) — Diluted EPS: 0.35
EQX.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 221471000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 187530000.00
EQX.TO income_statement (annual, 2025-12-31) — EBIT: 310655000.00
EQX.TO income_statement (quarterly, 2025-12-31) — EBIT: 66677000.00
EQX.TO income_statement (annual, 2025-12-31) — EBITDA: 828171000.00
EQX.TO income_statement (quarterly, 2025-12-31) — EBITDA: 218525000.00
EQX.TO cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 2896000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -290000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Employee Benefits: 26573000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 26573000.00
EQX.TO cash_flow (annual, 2025-12-31) — End Cash Position: 430004000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 430004000.00
EQX.TO cash_flow (annual, 2025-12-31) — Financing Cash Flow: -171893000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -131991000.00
EQX.TO cash_flow (annual, 2025-12-31) — Free Cash Flow: 125999000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 123070000.00
EQX.TO cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 113964000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 45280000.00
EQX.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -95763000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -61377000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 100597000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 100597000.00
EQX.TO income_statement (annual, 2025-12-31) — General And Administrative Expense: 103890000.00
EQX.TO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 25514000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Gross PPE: 8750310000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 8750310000.00
EQX.TO income_statement (annual, 2025-12-31) — Gross Profit: 642104000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Gross Profit: 168962000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Income Tax Payable: 153118000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 153118000.00
EQX.TO income_statement (annual, 2025-12-31) — Interest Expense: 179288000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Interest Expense: 34757000.00
EQX.TO income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 179288000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 34757000.00
EQX.TO income_statement (annual, 2025-12-31) — Interest Income: 10946000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Interest Income: 3163000.00
EQX.TO income_statement (annual, 2025-12-31) — Interest Income Non Operating: 10946000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 3163000.00
EQX.TO cash_flow (annual, 2025-12-31) — Interest Paid Cff: -132580000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Interest Paid Cff: -35814000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Inventory: 369759000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Inventory: 369759000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Invested Capital: 7349987000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 7349987000.00
EQX.TO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -458673000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -187569000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 0.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 0.00
EQX.TO balance_sheet (annual, 2025-12-31) — Investments And Advances: 0.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 0.00
EQX.TO cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
EQX.TO cash_flow (annual, 2025-12-31) — Issuance Of Debt: 85000000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
EQX.TO balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 73691000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 73691000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Long Term Debt: 1373350000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 1373350000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1447041000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1447041000.00
EQX.TO cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 85000000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
EQX.TO cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -146247000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -121055000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Long Term Provisions: 229821000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 229821000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 2536027000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 2536027000.00
EQX.TO cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 193107000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
EQX.TO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 0.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
EQX.TO balance_sheet (annual, 2025-12-31) — Net Debt: 1147325000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Net Debt: 1147325000.00
EQX.TO cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 21149000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 2623000.00
EQX.TO income_statement (annual, 2025-12-31) — Net Income: 221471000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Net Income: 187530000.00
EQX.TO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 221471000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 187530000.00
EQX.TO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -18861000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -52802000.00
EQX.TO income_statement (annual, 2025-12-31) — Net Income Discontinuous Operations: 240332000.00
EQX.TO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 221471000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 187530000.00
EQX.TO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -18861000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -52802000.00
EQX.TO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 221471000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 187530000.00
EQX.TO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 221471000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 187530000.00
EQX.TO income_statement (annual, 2025-12-31) — Net Interest Income: -168342000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: -31594000.00
EQX.TO cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -36977000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 0.00
EQX.TO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -61247000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -104496000.00
EQX.TO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -61247000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -121055000.00
EQX.TO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -168342000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -31594000.00
EQX.TO cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 21934000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 8319000.00
EQX.TO cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 77543000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 79511000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Net PPE: 7910329000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 7910329000.00
EQX.TO cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: -24878000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: -8319000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 5795307000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 5795307000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 0.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 0.00
EQX.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 1576981000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 1576981000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 165130000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 165130000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 0.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 0.00
EQX.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 1411851000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 1411851000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Non Current Note Receivables: 18750000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Non Current Note Receivables: 18750000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 19299000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 19299000.00
EQX.TO income_statement (annual, 2025-12-31) — Normalized EBITDA: 960041000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 291601000.00
EQX.TO income_statement (annual, 2025-12-31) — Normalized Income: 93228500.00
EQX.TO income_statement (quarterly, 2025-12-31) — Normalized Income: 9312600.00
EQX.TO cash_flow (annual, 2025-12-31) — Operating Cash Flow: 818345000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 390150000.00
EQX.TO cash_flow (annual, 2025-12-31) — Operating Gains Losses: 135113000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 47903000.00
EQX.TO income_statement (annual, 2025-12-31) — Operating Income: 432339000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Operating Income: 127806000.00
EQX.TO income_statement (annual, 2025-12-31) — Operating Revenue: 1817195000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 95821000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 785632450.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 785632450.00
EQX.TO balance_sheet (annual, 2025-12-31) — Other Current Assets: 10608000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 10608000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 181330000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 181330000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 497509000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 497509000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 100597000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 100597000.00
EQX.TO income_statement (annual, 2025-12-31) — Other Gand A: 38290000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Other Gand A: 10716000.00
EQX.TO income_statement (annual, 2025-12-31) — Other Income Expense: -132630000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Other Income Expense: -64292000.00
EQX.TO cash_flow (annual, 2025-12-31) — Other Non Cash Items: -20890000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -35674000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 635759000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 635759000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 150988000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 150988000.00
EQX.TO income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -760000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 8784000.00
EQX.TO income_statement (annual, 2025-12-31) — Other Operating Expenses: 10884000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Other Operating Expenses: -6414000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Other Receivables: 16958000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Other Receivables: 16958000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 162683000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 162683000.00
EQX.TO income_statement (annual, 2025-12-31) — Other Special Charges: -13042000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Other Special Charges: 0.00
EQX.TO balance_sheet (annual, 2025-12-31) — Payables: 265910000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Payables: 265910000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 455538000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 455538000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Prepaid Assets: 26352000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 26352000.00
EQX.TO income_statement (annual, 2025-12-31) — Pretax Income: 131367000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Pretax Income: 31920000.00
EQX.TO cash_flow (annual, 2025-12-31) — Purchase Of Business: 0.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 0.00
EQX.TO cash_flow (annual, 2025-12-31) — Purchase Of Investment: -40000000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: 0.00
EQX.TO balance_sheet (annual, 2025-12-31) — Receivables: 65468000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Receivables: 65468000.00
EQX.TO income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 1175091000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: -73141000.00
EQX.TO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 517516000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 151848000.00
EQX.TO cash_flow (annual, 2025-12-31) — Repayment Of Debt: -146247000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -104496000.00
EQX.TO income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 49149000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 11699000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Retained Earnings: 819998000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 819998000.00
EQX.TO income_statement (annual, 2025-12-31) — Salaries And Wages: 65600000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Salaries And Wages: 14798000.00
EQX.TO cash_flow (annual, 2025-12-31) — Sale Of Business: 193107000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Sale Of Business: 0.00
EQX.TO cash_flow (annual, 2025-12-31) — Sale Of Investment: 3023000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 0.00
EQX.TO income_statement (annual, 2025-12-31) — Selling General And Administration: 103890000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 25514000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Share Issued: 785632450.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Share Issued: 785632450.00
EQX.TO cash_flow (annual, 2025-12-31) — Short Term Debt Payments: -24878000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Short Term Debt Payments: -8319000.00
EQX.TO income_statement (annual, 2025-12-31) — Special Income Charges: -36107000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Special Income Charges: -11699000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 5795307000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 5795307000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 5795307000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 5795307000.00
EQX.TO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -19780500.00
EQX.TO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -10961400.00
EQX.TO income_statement (annual, 2025-12-31) — Tax Provision: 150228000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Tax Provision: 84722000.00
EQX.TO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.15
EQX.TO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.15
EQX.TO balance_sheet (annual, 2025-12-31) — Taxes Receivable: 41364000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 41364000.00
EQX.TO cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -129226000.00
EQX.TO cash_flow (quarterly, 2025-12-31) — Taxes Refund Paid: -83472000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Total Assets: 10535395000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Total Assets: 10535395000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Total Capitalization: 7168657000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 7168657000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Total Debt: 1628371000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Total Debt: 1628371000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 5795307000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 5795307000.00
EQX.TO income_statement (annual, 2025-12-31) — Total Expenses: 1384856000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Total Expenses: -31985000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 4740088000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 4740088000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 8564838000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 8564838000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 3478114000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 3478114000.00
EQX.TO income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 432339000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 127806000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Total Tax Payable: 161369000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 161369000.00
EQX.TO income_statement (annual, 2025-12-31) — Total Unusual Items: -131870000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items: -73076000.00
EQX.TO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -131870000.00
EQX.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -73076000.00
EQX.TO balance_sheet (annual, 2025-12-31) — Working Capital: 708583000.00
EQX.TO balance_sheet (quarterly, 2025-12-31) — Working Capital: 708583000.00
EQX.TO income_statement (quarterly, 2026-03-31) — +Operating Expense: 48264000.00
EQX.TO income_statement (quarterly, 2026-03-31) — +Total Revenue: 861593000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 335525000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 61149000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -962306000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 0.00
EQX.TO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 788596532.00
EQX.TO income_statement (quarterly, 2026-03-31) — Basic EPS: 0.39
EQX.TO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 407355000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -184842000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -184842000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 4903602000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 362965000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 499619000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -11838000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -1010399000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 708980000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 236842000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Change In Inventory: -81134000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -5730000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -7961000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Change In Receivables: -9337000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -104162000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Changes In Cash: -64577000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Common Stock: 4903602000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 6125220000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -4710000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 43831000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 423097000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Current Assets: 988309000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Current Debt: 29080000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 29080000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 101779000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 101779000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 797821000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 135960000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Deferred Tax: 135960000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 116100000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 49098000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 825750643.00
EQX.TO income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.38
EQX.TO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 310111000.00
EQX.TO income_statement (quarterly, 2026-03-31) — EBIT: 345704000.00
EQX.TO income_statement (quarterly, 2026-03-31) — EBITDA: 461804000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -2462000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — End Cash Position: 362965000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -1010399000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 52000000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 18857000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of Business: -105645000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -11347000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 95031000.00
EQX.TO income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 21206000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Gross PPE: 8911135000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Gross Profit: 438496000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 92959000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Interest Expense: 31693000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 31693000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Interest Income: 4201000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 4201000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Interest Paid Cff: -16713000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Inventory: 392045000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 6739949000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 708980000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 14308000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 585649000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 585649000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 14308000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -984526000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 232303000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 2631939000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 845181000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -4710000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Net Debt: 251764000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 5504000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Net Income: 310111000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 310111000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 187170000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Net Income Discontinuous Operations: 122941000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 310111000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 187170000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 310111000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 310111000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Net Interest Income: -27492000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 41146000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -970218000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -970218000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -27492000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -6920000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 7495000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Net PPE: 7948829000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 6125220000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 1613781000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 166284000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 1447497000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Non Current Note Receivables: 0.00
EQX.TO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 509830000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Normalized Income: 215985600.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 236842000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -48668000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Operating Income: 390232000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Operating Revenue: 861593000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 789078512.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Other Cash Adjustment Outside Changein Cash: 22649000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 2022000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 29080000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 238478000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 95031000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Other Gand A: 10982000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Other Income Expense: -48729000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -31420000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 718917000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 252183000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -703000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 6287000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 136654000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Other Special Charges: 32616000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Payables: 428484000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 428484000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 33474000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Pretax Income: 314011000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: 0.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Receivables: 61149000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 423097000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 116100000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -984526000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -4710000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 4063000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 1126587000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Salaries And Wages: 10224000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Sale Of Business: 845181000.00
EQX.TO cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 41146000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 21206000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Share Issued: 789078512.00
EQX.TO income_statement (quarterly, 2026-03-31) — Special Income Charges: -36679000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 6125220000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 6125220000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -19210400.00
EQX.TO income_statement (quarterly, 2026-03-31) — Tax Provision: 126841000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
EQX.TO cash_flow (quarterly, 2026-03-31) — Taxes Refund Paid: -141079000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Total Assets: 9656055000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 6710869000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Total Debt: 614729000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 6125220000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Total Expenses: 471361000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 3530835000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 8667746000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 2733014000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 390232000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 92959000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items: -48026000.00
EQX.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -48026000.00
EQX.TO balance_sheet (quarterly, 2026-03-31) — Working Capital: 190488000.00
ER7.DE balance_sheet (annual, 2021-12-31) — Accounts Receivable: 375000000.00
ER7.DE balance_sheet (annual, 2021-12-31) — Assets Held For Sale Current: 651000000.00
ER7.DE balance_sheet (annual, 2021-12-31) — Available For Sale Securities: 175000000.00
ER7.DE balance_sheet (annual, 2021-12-31) — Cash Cash Equivalents And Short Term Investments: 1176000000.00
ER7.DE cash_flow (annual, 2021-12-31) — Cash Dividends Paid: -4000000.00
ER7.DE cash_flow (annual, 2021-12-31) — Change In Working Capital: -80000000.00
ER7.DE cash_flow (annual, 2021-12-31) — Changes In Cash: -662000000.00
ER7.DE cash_flow (annual, 2021-12-31) — Common Stock Issuance: 120000000.00
ER7.DE balance_sheet (annual, 2021-12-31) — Current Debt And Capital Lease Obligation: 468000000.00
ER7.DE balance_sheet (annual, 2021-12-31) — Current Liabilities: 2148000000.00
ER7.DE cash_flow (annual, 2021-12-31) — Depreciation And Amortization: 142000000.00
ER7.DE cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: -12000000.00
ER7.DE income_statement (annual, 2021-12-31) — General And Administrative Expense: 1149000000.00
ER7.DE balance_sheet (annual, 2021-12-31) — Goodwill And Other Intangible Assets: 361000000.00
ER7.DE balance_sheet (annual, 2021-12-31) — Investmentin Financial Assets: 175000000.00
ER7.DE cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 120000000.00
ER7.DE balance_sheet (annual, 2021-12-31) — Long Term Provisions: 786000000.00
ER7.DE cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: -8000000.00
ER7.DE income_statement (annual, 2021-12-31) — Net Income Discontinuous Operations: -426000000.00
ER7.DE cash_flow (annual, 2021-12-31) — Net PPE Purchase And Sale: 2000000.00
ER7.DE balance_sheet (annual, 2021-12-31) — Other Current Liabilities: 143000000.00
ER7.DE balance_sheet (annual, 2021-12-31) — Other Non Current Assets: 1000000.00
ER7.DE balance_sheet (annual, 2021-12-31) — Other Payable: 143000000.00
ER7.DE balance_sheet (annual, 2021-12-31) — Other Short Term Investments: 387000000.00
ER7.DE income_statement (annual, 2021-12-31) — Other Special Charges: 2000000.00
ER7.DE balance_sheet (annual, 2021-12-31) — Payables: 763000000.00
ER7.DE income_statement (annual, 2021-12-31) — Reconciled Depreciation: 142000000.00
ER7.DE cash_flow (annual, 2021-12-31) — Repurchase Of Capital Stock: -8000000.00
ER7.DE income_statement (annual, 2021-12-31) — Research And Development: 21000000.00
ER7.DE cash_flow (annual, 2021-12-31) — Sale Of Business: 6000000.00
ER7.DE income_statement (annual, 2021-12-31) — Selling General And Administration: 1149000000.00
ER7.DE balance_sheet (annual, 2021-12-31) — Total Equity Gross Minority Interest: 1335000000.00
ER7.DE balance_sheet (annual, 2021-12-31) — Working Capital: 969000000.00
ER7.DE income_statement (annual, 2022-12-31) — +Operating Expense: 2072000000.00
ER7.DE income_statement (annual, 2022-12-31) — +Total Revenue: 5102000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Accounts Payable: 424000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Accounts Receivable: 369000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -3768000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 466000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -14000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 714000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 13000000.00
ER7.DE income_statement (annual, 2022-12-31) — Basic Average Shares: 28674721.00
ER7.DE income_statement (annual, 2022-12-31) — Basic EPS: 25.81
ER7.DE cash_flow (annual, 2022-12-31) — Beginning Cash Position: 789000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 69000000.00
ER7.DE cash_flow (annual, 2022-12-31) — Capital Expenditure: -588000000.00
ER7.DE cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -530000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 91000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Capital Stock: 88000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 1123000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 1660000000.00
ER7.DE cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -72000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Cash Equivalents: 837000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Cash Financial: 286000000.00
ER7.DE cash_flow (annual, 2022-12-31) — Change In Inventory: -150000000.00
ER7.DE cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 54000000.00
ER7.DE cash_flow (annual, 2022-12-31) — Change In Payable: -21000000.00
ER7.DE cash_flow (annual, 2022-12-31) — Change In Receivables: 6000000.00
ER7.DE cash_flow (annual, 2022-12-31) — Change In Working Capital: -111000000.00
ER7.DE cash_flow (annual, 2022-12-31) — Changes In Cash: 418000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Common Stock: 88000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Common Stock Equity: 1781000000.00
ER7.DE cash_flow (annual, 2022-12-31) — Common Stock Issuance: 167000000.00
ER7.DE cash_flow (annual, 2022-12-31) — Common Stock Payments: -7000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Construction In Progress: 768000000.00
ER7.DE income_statement (annual, 2022-12-31) — Cost Of Revenue: 1766000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Current Assets: 3982000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 16000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Current Debt: 520000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 536000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Current Liabilities: 2517000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Current Provisions: 162000000.00
ER7.DE cash_flow (annual, 2022-12-31) — Deferred Tax: 18000000.00
ER7.DE cash_flow (annual, 2022-12-31) — Depreciation: 489000000.00
ER7.DE cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 489000000.00
ER7.DE income_statement (annual, 2022-12-31) — Diluted Average Shares: 29037022.00
ER7.DE income_statement (annual, 2022-12-31) — Diluted EPS: 25.49
ER7.DE income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 740000000.00
ER7.DE cash_flow (annual, 2022-12-31) — Dividends Received Cfi: 25000000.00
ER7.DE income_statement (annual, 2022-12-31) — EBIT: 1303000000.00
ER7.DE income_statement (annual, 2022-12-31) — EBITDA: 1792000000.00
ER7.DE cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -64000000.00
ER7.DE cash_flow (annual, 2022-12-31) — End Cash Position: 1123000000.00
ER7.DE cash_flow (annual, 2022-12-31) — Financing Cash Flow: -60000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Finished Goods: 198000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Fixed Assets Revaluation Reserve: 7000000.00
ER7.DE cash_flow (annual, 2022-12-31) — Free Cash Flow: 403000000.00
ER7.DE cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 189000000.00
ER7.DE cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 3000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Goodwill: 208000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 375000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 383000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Gross PPE: 2409000000.00
ER7.DE income_statement (annual, 2022-12-31) — Gross Profit: 3336000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Hedging Assets Current: 75000000.00
ER7.DE income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 221000000.00
ER7.DE income_statement (annual, 2022-12-31) — Interest Expense: 109000000.00
ER7.DE income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 109000000.00
ER7.DE income_statement (annual, 2022-12-31) — Interest Income: 8000000.00
ER7.DE income_statement (annual, 2022-12-31) — Interest Income Non Operating: 8000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Inventory: 724000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Invested Capital: 3694000000.00
ER7.DE cash_flow (annual, 2022-12-31) — Investing Cash Flow: -513000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 13000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Investmentsin Associatesat Cost: 297000000.00
ER7.DE cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 167000000.00
ER7.DE cash_flow (annual, 2022-12-31) — Issuance Of Debt: 167000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Land And Improvements: 208000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 75000000.00
ER7.DE balance_sheet (annual, 2022-12-31) — Long Term Debt: 1393000000.00